AC
ELV icon

AlphaCore Capital’s Elevance Health ELV Stock Holding History

AlphaCore Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.74M Buy
4,509
+472
+12% +$175K 0.03% 339
2026
Q1 		$1.18M Buy
4,037
+1,187
+42% +$390K 0.03% 347
2025
Q4 		$999K Buy
2,850
+1,779
+166% +$601K 0.02% 419
2025
Q3 		$346K Buy
1,071
+303
+39% +$94.2K 0.01% 551
2025
Q2 		$299K Buy
768
+174
+29% +$70K 0.01% 486
2025
Q1 		$258K Buy
+594
New +$238K 0.02% 388
2024
Q4 		– Sell
-499
Closed -$259K – 268
2024
Q3 		$259K Sell
499
-37
-7% -$19.8K 0.06% 176
2024
Q2 		$290K Buy
+536
New +$283K 0.07% 158

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AlphaCore Capital's ELV Position: Q2 2026 in Review

AlphaCore Capital increased its Elevance Health (ELV) stake by 12% in Q2 2026, buying an estimated $175K and bringing the position to 4,509 shares worth $1.74M. The position accounts for 0.03% of the portfolio, ranked #339.

AlphaCore Capital first reported a position in ELV in Q2 2024 and has held it in 8 quarters since. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • AlphaCore Capital held 4,509 shares of Elevance Health worth $1.74M as of Q2 2026.
  • AlphaCore Capital bought 472 Elevance Health shares in Q2 2026, an estimated $175K.
  • Elevance Health made up 0.03% of AlphaCore Capital's portfolio in Q2 2026, its #339 holding.
  • AlphaCore Capital first reported a position in Elevance Health in Q2 2024 and has held it in 8 quarters since.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on AlphaCore Capital's 13F filing for Q2 2026, filed 6 Aug 2026.